Guenther, Michael; Gil, Lina; Surendran, Sai Agash; Palm, Melanie Alexandra; Heinemann, Volker; von Bergwelt-Baildon, Michael; Mayerle, Julia; Engel, Jutta; Werner, Jens; Boeck, Stefan; Ormanns, Steffen (2022): Bacterial lipopolysaccharide as a negative predictor of adjuvant gemcitabine efficacy in pancreatic cancer. JNCI Cancer Spectrum: pkac039. ISSN 2515-5091
Dorman, Klara; Breitenwieser, Kilian; Fischer, Laura; Zhang, Danmei; Probst, Victoria; Weiss, Lena; Heinrich, Kathrin; Kunz, Wolfgang G.
ORCID: 0000-0002-5021-1952; Holch, Julian W.; Gießen-Jung, Clemens; Haas, Michael; Boeck, Stefan; Bergwelt-Baildon, Michael von; Landfarth, Timotheus; Hornung, Roman; Casuscelli, Jozefina; Berger-Thürmel, Karin; Heinemann, Volker; Westphalen, C. Benedikt; Reischer, Anna
(2025):
Real-world analysis of immune checkpoint inhibitor efficacy and response predictors in patients treated at the CCCMunichLMU outpatient clinic.
Scientific Reports, 15: 43269.
ISSN 2045-2322
Fey, Theres; Kasprzak, Julia; Ernst, Julia; Weiher, Franziska; Schmid, Marina; Erickson, Nicole; Kühnel, Brigitte; Prompinit, Wuthichai; Tanzer-Küntzer, Sylvia; Algül, Hana; Heinemann, Volker; Nasseh, Daniel (2025): Information and support for cancer patients and their relatives - evaluation of central contact point enquiries: a retrospective analysis. BMC Health Services Research, 25: 1192. ISSN 1472-6963
Mansour, Nabeel; Heinrich, Kathrin; Zhang, Danmei; Winkelmann, Michael; Ingenerf, Maria; Gold, Lukas; Klambauer, Konstantin; Rudelius, Martina; Klauschen, Frederick; Bergwelt-Baildon, Michael von; Ricke, Jens; Heinemann, Volker; Westphalen, C. Benedikt; Kunz, Wolfgang G. (2024): Patient eligibility for trials with imaging response assessment at the time of molecular tumor board presentation. Cancer Imaging, 24 (1). ISSN 1470-7330
Pretzsch, Elise; Heinemann, Volker; Stintzing, Sebastian; Bender, Andreas; Chen, Shuo; Holch, Julian Walter; Hofmann, Felix Oliver; Ren, Haoyu; Bösch, Florian; Küchenhoff, Helmut; Werner, Jens; Angele, Martin Konrad (2022): EMT-Related Genes Have No Prognostic Relevance in Metastatic Colorectal Cancer as Opposed to Stage II/III: Analysis of the Randomised, Phase III Trial FIRE-3 (AIO KRK 0306; FIRE-3). Cancers, 14 (22): 5596. ISSN 2072-6694